Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sainsbury's terminates Argos sale talks

(Sharecast News) - Talks between J Sainsbury's and China's JD.com over the potential sale of Argos have collapsed, the supermarket chain confirmed on Monday. In a brief statement, the blue chip retailer said JD.com was now only prepared to engage on a "materially revised" set of terms and commitments, which were not in the best interest of shareholders.

It continued: "Accordingly, Sainsbury's confirms that it has now terminated discussions with JD.com."

The e-commerce giant has yet to comment.

It emerged over the weekend that JD.com was interested in Argos-parent Home Retail Group, which Sainsbury's acquired in 2016 for £1.4bn.

JD.com, China's largest online retailer, is known to be looking to expand outside of its home market.

Sainsbury's initially said JD.com would bring "world-class retail, technology and logistics expertise, and invest to drive Argos' growth and further transform the customer experience".

Argos is UK's second-biggest general merchandise brand but has often weighed on Sainsbury's performance. Chief executive, Simon Roberts is also tying to refocus the supermarket on its core food offering.

Last year he sold off Sainsbury's Bank's loan, credit card and retail deposit portfolios, and in July the travel money business was acquired by Fexco Group.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.